BAFF-Rezeptor (BCMA), ein immunregulatorischer Wirkstoff

Patent europeic · EP1806143 · Stritgà

Inscripziun en il register

Numer da publicaziun
EP1806143
Numer da la dumonda
EP07100908
Gener
Patent europeic cun effect per la Svizra ed il Liechtenstein
Status
Stritgà
Scrittira da patent
Concedì
Annunzià
16-08-2000
Publitgà
11-07-2007
Concedì
15-06-2016
Stritgà
15-08-2020
Motiv
Durada maximala cuntanschida
Classas IPC
A61K 38/17 (2006.01)
A61K 39/395 (2006.01)
A61P 37/00 (2006.01)
A61P 9/12 (2006.01)
A61P 13/12 (2006.01)
C07K 16/28 (2006.01)
Prioritad
US 149378 P 17.08.1999
US 181684 P 11.02.2000
US 183536 P 18.02.2000
Derivà da
EP00957502
Lingua da l’annunzia
englais
Funtauna
Swissreg

Istorgia

Quai che l’Institut federal da la proprietad intellectuala ha publitgà davart quest titel, il pli nov l’emprim.

  1. 17-08-2020

    Durada maximala cuntanschida

    Published in Swissreg on 17.08.2020

  2. 15-06-2016

    Concedì

    Published in Swissreg on 15.06.2016

Partidas

Possessur

Biogen MA Inc.

250 Binney Street, Cambridge, MA 02142, US

Topotarget Switzerland SA, en liquidation

Topotarget Switzerland SA

Avenue de Sévelin 18-20, 1004 Lausanne

En liquidaziun

Inventur

Mackay, Fabienne

Vaucluse, NSW 2030, AU

Browning, Jeffrey

Brookline, MA 02146, US

Ambrose, Christine

Reading, MA 01867, US

Tschopp, Jurg

1066 Epalinges

Schneider, Pascal

1066 Epalinges

Thompson, Jeffrey

Stoneham, MA 02180, US

Il register numna mintga partida cun num ed adressa. In possessur u in represchentant vegn collià cun in’organisaziun, sch’exact ina unitad giuridica dal register da commerzi porta ses num; la via d’ina partida betg enconuschida uschia na vegn betg mussada qua.